← Every applicant
Almatica FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DULOXETINE HYDROCHLORIDENew drugFeb 27, 2026CAPSULE, DELAYED REL PELLETS, ORAL |
| ESCITALOPRAMNew drugAug 29, 2025CAPSULE, ORAL |
| ZOLPIDEM TARTRATENew drugMay 9, 2023CAPSULE, ORAL |
| VENLAFAXINE BESYLATENew drugJun 29, 2022TABLET, EXTENDED RELEASE, ORAL |
| CITALOPRAM HYDROBROMIDENew drugJan 31, 2022CAPSULE, ORAL |
| SERTRALINE HYDROCHLORIDENew drugOct 4, 2021CAPSULE, ORAL |
| LOREEV XRNew drugAug 27, 2021CAPSULE, EXTENDED RELEASE, ORAL |